Multi-Cancer Detection Observational Cohort Study

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Mayo Clinic
Study ID
NCT06962995
Status
Recruiting

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Blood Sample — PROCEDURE
    Up to 60 mL (about 4-5 Tbsp) of blood may be collected for an initial blood draw and up to 30 mL (about 2-3 Tbsp) may be collected for a second blood draw, 25-45 days after first blood draw. The research blood will be collected at the time of a clinical blood draw, if possible.
  • Surveys — OTHER
    Participants will complete surveys related to attitudes and beliefs around Multi-Cancer Detection testing.

Study Details

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

Key Dates

Start date
May 7, 2025
Status verified
Mar 2026
Primary completion
Jun 30, 2029
Completion
Jun 30, 2029

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Observational
    Patients complete surveys and have their medical records reviewed on study. Patients may undergo blood or buccal swab and urine sample collection on study.

Primary Outcome Measure

Financial impact of MCD testing [ Time Frame: Up to 5 years ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Mayo Clinic in ArizonaScottsdaleArizona85259
Clinical Trials Referral Office
855-776-0015
Jewel Samadder, MD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in FloridaJacksonvilleFlorida32224-9980
Clinical Trials Referral Office
855-776-0015
R. John Presutti, DO (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
855-776-0015
Ryan Hurt, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

Related Studies